XTL BIOPHARMACEUTICALS LTD. Increase Decrease Through Acquisition Of Subsidiary
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Increase Decrease Through Acquisition Of Subsidiary of $84.00 thousand for the 12-month period ending 2015-12-31, per its 20-F filed 2018-03-15.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary · last filed 2018-03-15
| Period end | Increase Decrease Through Acquisition Of Subsidiary 12 month |
|---|---|
| 2015-12-31 | $84.00K 20-F · filed 2018-03-15 |